Supreme Healthcare Limited to Sell 14 Lakh Shares in IPO
January 21, 2026 | Investopaper
Supreme Healthcare Limited is in the process of issuing shares to the public (IPO). For this purpose, the company has submitted the application to the Securities Board of Nepal (SEBON) on Magh 6, 2082 BS. Only after the approval from the regulatory body SEBON, the company can sell shares to the public.
If approved by SEBON, the company plans to sell 14,00,000 shares that amounts to Rs. 14 crores in the public offering.
For this purpose, the company has appointed Global IME Capital Limited as the issue and sales manager. The agreement for public offering has already been signed between the company and Global IME Capital Limited on this regard.
In the first phase, the company will sell shares to the foreign employed Nepalis. Likewise, in the second phase, the company will float shares to the general public, including the employees of the company and the mutual fund schemes.
About Supreme Healthcare Limited
Supreme Healthcare Limited is a pharma company based in Bara, Nepal. It manufactures and markets pharmaceutical products focusing on cardiology, gastroenterology, dermatology, and antibiotics.
Recommended:
